NCT02446496View on ClinicalTrials.gov

A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 8, 2014

Study Completion Date

April 8, 2014

Conditions
Infections, Urinary Tract
Interventions
DRUG

Cefadroxil tablets manufactured by GSK

Cefadroxil tablets manufactured by GSK contains 1 mg of Cefadroxil

DRUG

Cefadroxil tablets manufactured by NP

Cefadroxil tablets manufactured by NP contains 1 mg of Cefadroxil

Trial Locations (1)

Unknown

GSK Investigational Site, Cairo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02446496 - A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects | Biotech Hunter | Biotech Hunter